Inhibikase Therapeutics, Inc. (IKT)
1.65
+0.06
(+3.77%)
USD |
NASDAQ |
Dec 24, 16:00
Inhibikase Therapeutics Price: 1.65 for Dec. 24, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 4.68 |
| AIM ImmunoTech, Inc. | 1.28 |
| IGC Pharma, Inc. | 0.3032 |
| NovaBay Pharmaceuticals, Inc. | 4.75 |
| Protalix Biotherapeutics, Inc. | 1.77 |
Price Related Metrics
| Price to Book Value | 2.745 |
| Earnings Yield | -34.57% |
| Market Cap | 200.09M |